Literature DB >> 12872237

Comparison of the Escherichia coli proteomes for recombinant human growth hormone producing and nonproducing fermentations.

Kathleen M Champion1, Julie C Nishihara, Ilana S Aldor, G Tony Moreno, Dana Andersen, Kathy L Stults, Martin Vanderlaan.   

Abstract

Two-dimensional electrophoretic analyses of Escherichia coli cells producing recombinant human growth hormone (Nutropin) in fermentations were conducted. The resulting two-dimensional protein profiles were compared with those of nonproducing (blank) cells. A qualitative comparison was performed to address regulatory issues in the biopharmaceutical industry, and a semiquantitative comparison was performed to reveal information about the physiological state of the cells. The protein spots unique to production fermentation profiles were all related to recombinant human growth hormone (hGH); these included intact hGH, charge variants of hGH, and a proteolytically cleaved form of hGH, as expected. There were no E. coli host cell proteins unique to either the production or blank fermentation profiles. Rather, all detectable differences in E. coli proteins were quantitative in nature. Specifically, the levels of IbpA (inclusion body binding protein A), Ivy (inhibitor of vertebrate lysozyme), and a cleaved form of GroEL (Hsp60 homolog) were higher in hGH production profiles, whereas the levels of GlmU protein and PspA (phage shock protein A) were higher in blank profiles. In general, the high degree of similarity between proteomes for hGH-producing and nonproducing cells suggests that E. coli proteins from a nonproducing (blank) fermentation are appropriate for eliciting antibodies that are then used in immunoassays to measure host cell proteins in samples from production fermentations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12872237     DOI: 10.1002/pmic.200300430

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  6 in total

1.  Proteomic profiling of recombinant Escherichia coli in high-cell-density fermentations for improved production of an antibody fragment biopharmaceutical.

Authors:  Ilana S Aldor; Denise C Krawitz; William Forrest; Christina Chen; Julie C Nishihara; John C Joly; Kathleen M Champion
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

2.  Recombinant E. coli expressing Vitreoscilla haemoglobin prefers aerobic metabolism under microaerobic conditions: a proteome-level study.

Authors:  Bini Ramachandran; Kanak Lata Dikshit; Kuppamuthu Dharmalingam
Journal:  J Biosci       Date:  2012-09       Impact factor: 1.826

Review 3.  The Escherichia coli proteome: past, present, and future prospects.

Authors:  Mee-Jung Han; Sang Yup Lee
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

4.  Protein solubility and differential proteomic profiling of recombinant Escherichia coli overexpressing double-tagged fusion proteins.

Authors:  Chung-Hsien Cheng; Wen-Chien Lee
Journal:  Microb Cell Fact       Date:  2010-08-28       Impact factor: 5.328

Review 5.  Isolating Escherichia coli strains for recombinant protein production.

Authors:  Susan Schlegel; Pierre Genevaux; Jan-Willem de Gier
Journal:  Cell Mol Life Sci       Date:  2016-10-11       Impact factor: 9.261

Review 6.  Strategies to Enhance Periplasmic Recombinant Protein Production Yields in Escherichia coli.

Authors:  Alexandros Karyolaimos; Jan-Willem de Gier
Journal:  Front Bioeng Biotechnol       Date:  2021-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.